Laser Therapy Versus Neuromuscular Electrical Nerve Stimulation at Hemiplegic Shoulder Pain
Launched by HITIT UNIVERSITY · May 22, 2024
Trial Information
Current as of February 14, 2025
Completed
Keywords
ClinConnect Summary
Cerebrovascular events, which are estimated to affect approximately 9 million people worldwide, have emerged as a serious cause of morbidity and mortality due to prolonged human lifespan. With the use of effective treatment methods in acute treatment, the level of expectation regarding prognosis has increased. Secondary complications that develop after stroke are frequently encountered. These complications cause serious disruptions in the rehabilitation process. The upper extremity is affected more frequently than the lower extremity and recovery is more difficult and slower. Most of the fu...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • diagnosed with unilateral ischemic stroke for the first time
- • 18-85 years old,
- • patients with shoulder pain
- Exclusion Criteria:
- • another disease that will affect the central nervous system
- • injections or physical therapy to the same shoulder in the last 3 months,
- • history of shoulder surgery,
- • cervical radiculopathy,
- • inflammatory rheumatic disease or infection,
- • serious cardiovascular disease such as heart failure, arrhythmia, myocardial infarction that will affect functional status,
- • disease that will cause cognitive dysfunction,
- • Alzheimer's disease, dementia,
- • severe visual loss,
- • pregnancy and lactation,
- • malignancy,
- • psychiatric diseases
Trial Officials
MUSTAFA KESER, Ass Prof
Study Chair
HİTİT UNİVERSİTY EROL OLÇOK RESEARCH HOSPİTAL
About Hitit University
Hitit University is a leading academic institution committed to advancing medical research and innovation through rigorous clinical trials. With a focus on enhancing healthcare outcomes, the university fosters collaboration between interdisciplinary teams of researchers, clinicians, and healthcare professionals. Hitit University is dedicated to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical studies. By leveraging cutting-edge technologies and methodologies, the university aims to contribute to the global body of knowledge in medicine and improve patient care through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Corum, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0